Polymer microfluidic chips for in vitro diagnosis are a technical platform that integrates basic operating units such as sample preparation, reaction, separation, and detection in the fields of chemistry and biology. Its core lies in the precise manipulation of fluids in micrometer-scale space. Polymer microfluidic chips are chips that use polymer materials (such as polydimethylsiloxane PDMS, etc.) to form a microchannel network structure through etching or molding technology. These microchannels are used to guide and control tiny volumes of fluids (including liquids and gases) to achieve various biochemical reactions and detection processes required for in vitro diagnosis.
The global Polymer Microfluidic Chips for in Vitro Diagnostics market size is projected to grow from US$ 398 million in 2024 to US$ 772 million in 2030; it is expected to grow at a CAGR of 11.7% from 2024 to 2030.
The 鈥淧olymer Microfluidic Chips for in Vitro Diagnostics Industry Forecast鈥� looks at past sales and reviews total world Polymer Microfluidic Chips for in Vitro Diagnostics sales in 2023, providing a comprehensive analysis by region and market sector of projected Polymer Microfluidic Chips for in Vitro Diagnostics sales for 2024 through 2030. With Polymer Microfluidic Chips for in Vitro Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polymer Microfluidic Chips for in Vitro Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Polymer Microfluidic Chips for in Vitro Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polymer Microfluidic Chips for in Vitro Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Polymer Microfluidic Chips for in Vitro Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polymer Microfluidic Chips for in Vitro Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polymer Microfluidic Chips for in Vitro Diagnostics.
In vitro diagnosis is one of the important application markets of polymer microfluidic chips. The application of microfluidic chips in disease diagnosis can simplify the diagnostic process, improve the diagnostic speed, improve the diagnostic efficiency, reduce the demand for consumables, and reduce the diagnostic cost. It has become the mainstream technology of the new generation of bedside rapid testing (POCT). Polymer-based microfluidic chips occupy an important position in the market due to their low cost, good flexibility and easy manufacturing. With the continuous emergence of new polymer materials, such as conductive polymers and photosensitive polymers, more possibilities are provided for the development of polymer microfluidic chips. In summary, the market for polymer microfluidic chips for in vitro diagnosis will continue to maintain a rapid growth trend in the next few years.
This report presents a comprehensive overview, market shares, and growth opportunities of Polymer Microfluidic Chips for in Vitro Diagnostics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Continuous Flow Microfluidic Chip
Digital Microfluidic Chip
Other
Segmentation by Application:
Biochemical Diagnosis
Immunodiagnosis
Molecular Diagnosis
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Agilent Technologies
Fluidigm Corporation
PerkinElmer
Micronit Microfluidics
Dolomite Microfluidics
Sony DADC BioSciences
MicroLIQUID
Micronit Microtechnologies
Suzhou Hanguang Micro-Nano Technology
Micropoint Bio
Xingeyuan Bio
Lanyu Bio
Bohui Innovation
Rongzhi Bio
Jiangsu Huixian Pharmaceutical
Ruixun Bio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Polymer Microfluidic Chips for in Vitro Diagnostics market?
What factors are driving Polymer Microfluidic Chips for in Vitro Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Polymer Microfluidic Chips for in Vitro Diagnostics market opportunities vary by end market size?
How does Polymer Microfluidic Chips for in Vitro Diagnostics break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Polymer Microfluidic Chips for in Vitro Diagnostics Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Polymer Microfluidic Chips for in Vitro Diagnostics by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Polymer Microfluidic Chips for in Vitro Diagnostics by Country/Region, 2019, 2023 & 2030
2.2 Polymer Microfluidic Chips for in Vitro Diagnostics Segment by Type
2.2.1 Continuous Flow Microfluidic Chip
2.2.2 Digital Microfluidic Chip
2.2.3 Other
2.3 Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Type
2.3.1 Global Polymer Microfluidic Chips for in Vitro Diagnostics Sales Market Share by Type (2019-2024)
2.3.2 Global Polymer Microfluidic Chips for in Vitro Diagnostics Revenue and Market Share by Type (2019-2024)
2.3.3 Global Polymer Microfluidic Chips for in Vitro Diagnostics Sale Price by Type (2019-2024)
2.4 Polymer Microfluidic Chips for in Vitro Diagnostics Segment by Application
2.4.1 Biochemical Diagnosis
2.4.2 Immunodiagnosis
2.4.3 Molecular Diagnosis
2.4.4 Other
2.5 Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Application
2.5.1 Global Polymer Microfluidic Chips for in Vitro Diagnostics Sale Market Share by Application (2019-2024)
2.5.2 Global Polymer Microfluidic Chips for in Vitro Diagnostics Revenue and Market Share by Application (2019-2024)
2.5.3 Global Polymer Microfluidic Chips for in Vitro Diagnostics Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Polymer Microfluidic Chips for in Vitro Diagnostics Breakdown Data by Company
3.1.1 Global Polymer Microfluidic Chips for in Vitro Diagnostics Annual Sales by Company (2019-2024)
3.1.2 Global Polymer Microfluidic Chips for in Vitro Diagnostics Sales Market Share by Company (2019-2024)
3.2 Global Polymer Microfluidic Chips for in Vitro Diagnostics Annual Revenue by Company (2019-2024)
3.2.1 Global Polymer Microfluidic Chips for in Vitro Diagnostics Revenue by Company (2019-2024)
3.2.2 Global Polymer Microfluidic Chips for in Vitro Diagnostics Revenue Market Share by Company (2019-2024)
3.3 Global Polymer Microfluidic Chips for in Vitro Diagnostics Sale Price by Company
3.4 Key Manufacturers Polymer Microfluidic Chips for in Vitro Diagnostics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Polymer Microfluidic Chips for in Vitro Diagnostics Product Location Distribution
3.4.2 Players Polymer Microfluidic Chips for in Vitro Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Polymer Microfluidic Chips for in Vitro Diagnostics by Geographic Region
4.1 World Historic Polymer Microfluidic Chips for in Vitro Diagnostics Market Size by Geographic Region (2019-2024)
4.1.1 Global Polymer Microfluidic Chips for in Vitro Diagnostics Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Polymer Microfluidic Chips for in Vitro Diagnostics Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Polymer Microfluidic Chips for in Vitro Diagnostics Market Size by Country/Region (2019-2024)
4.2.1 Global Polymer Microfluidic Chips for in Vitro Diagnostics Annual Sales by Country/Region (2019-2024)
4.2.2 Global Polymer Microfluidic Chips for in Vitro Diagnostics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Polymer Microfluidic Chips for in Vitro Diagnostics Sales Growth
4.4 APAC Polymer Microfluidic Chips for in Vitro Diagnostics Sales Growth
4.5 Europe Polymer Microfluidic Chips for in Vitro Diagnostics Sales Growth
4.6 Middle East & Africa Polymer Microfluidic Chips for in Vitro Diagnostics Sales Growth
5 Americas
5.1 Americas Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Country
5.1.1 Americas Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Country (2019-2024)
5.1.2 Americas Polymer Microfluidic Chips for in Vitro Diagnostics Revenue by Country (2019-2024)
5.2 Americas Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Type (2019-2024)
5.3 Americas Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Region
6.1.1 APAC Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Region (2019-2024)
6.1.2 APAC Polymer Microfluidic Chips for in Vitro Diagnostics Revenue by Region (2019-2024)
6.2 APAC Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Type (2019-2024)
6.3 APAC Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Polymer Microfluidic Chips for in Vitro Diagnostics by Country
7.1.1 Europe Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Country (2019-2024)
7.1.2 Europe Polymer Microfluidic Chips for in Vitro Diagnostics Revenue by Country (2019-2024)
7.2 Europe Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Type (2019-2024)
7.3 Europe Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Polymer Microfluidic Chips for in Vitro Diagnostics by Country
8.1.1 Middle East & Africa Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Country (2019-2024)
8.1.2 Middle East & Africa Polymer Microfluidic Chips for in Vitro Diagnostics Revenue by Country (2019-2024)
8.2 Middle East & Africa Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Type (2019-2024)
8.3 Middle East & Africa Polymer Microfluidic Chips for in Vitro Diagnostics Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polymer Microfluidic Chips for in Vitro Diagnostics
10.3 Manufacturing Process Analysis of Polymer Microfluidic Chips for in Vitro Diagnostics
10.4 Industry Chain Structure of Polymer Microfluidic Chips for in Vitro Diagnostics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Polymer Microfluidic Chips for in Vitro Diagnostics Distributors
11.3 Polymer Microfluidic Chips for in Vitro Diagnostics Customer
12 World Forecast Review for Polymer Microfluidic Chips for in Vitro Diagnostics by Geographic Region
12.1 Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Size Forecast by Region
12.1.1 Global Polymer Microfluidic Chips for in Vitro Diagnostics Forecast by Region (2025-2030)
12.1.2 Global Polymer Microfluidic Chips for in Vitro Diagnostics Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Polymer Microfluidic Chips for in Vitro Diagnostics Forecast by Type (2025-2030)
12.7 Global Polymer Microfluidic Chips for in Vitro Diagnostics Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Agilent Technologies
13.1.1 Agilent Technologies Company Information
13.1.2 Agilent Technologies Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.1.3 Agilent Technologies Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Agilent Technologies Main Business Overview
13.1.5 Agilent Technologies Latest Developments
13.2 Fluidigm Corporation
13.2.1 Fluidigm Corporation Company Information
13.2.2 Fluidigm Corporation Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.2.3 Fluidigm Corporation Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Fluidigm Corporation Main Business Overview
13.2.5 Fluidigm Corporation Latest Developments
13.3 PerkinElmer
13.3.1 PerkinElmer Company Information
13.3.2 PerkinElmer Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.3.3 PerkinElmer Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 PerkinElmer Main Business Overview
13.3.5 PerkinElmer Latest Developments
13.4 Micronit Microfluidics
13.4.1 Micronit Microfluidics Company Information
13.4.2 Micronit Microfluidics Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.4.3 Micronit Microfluidics Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Micronit Microfluidics Main Business Overview
13.4.5 Micronit Microfluidics Latest Developments
13.5 Dolomite Microfluidics
13.5.1 Dolomite Microfluidics Company Information
13.5.2 Dolomite Microfluidics Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.5.3 Dolomite Microfluidics Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Dolomite Microfluidics Main Business Overview
13.5.5 Dolomite Microfluidics Latest Developments
13.6 Sony DADC BioSciences
13.6.1 Sony DADC BioSciences Company Information
13.6.2 Sony DADC BioSciences Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.6.3 Sony DADC BioSciences Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sony DADC BioSciences Main Business Overview
13.6.5 Sony DADC BioSciences Latest Developments
13.7 MicroLIQUID
13.7.1 MicroLIQUID Company Information
13.7.2 MicroLIQUID Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.7.3 MicroLIQUID Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 MicroLIQUID Main Business Overview
13.7.5 MicroLIQUID Latest Developments
13.8 Micronit Microtechnologies
13.8.1 Micronit Microtechnologies Company Information
13.8.2 Micronit Microtechnologies Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.8.3 Micronit Microtechnologies Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Micronit Microtechnologies Main Business Overview
13.8.5 Micronit Microtechnologies Latest Developments
13.9 Suzhou Hanguang Micro-Nano Technology
13.9.1 Suzhou Hanguang Micro-Nano Technology Company Information
13.9.2 Suzhou Hanguang Micro-Nano Technology Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.9.3 Suzhou Hanguang Micro-Nano Technology Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Suzhou Hanguang Micro-Nano Technology Main Business Overview
13.9.5 Suzhou Hanguang Micro-Nano Technology Latest Developments
13.10 Micropoint Bio
13.10.1 Micropoint Bio Company Information
13.10.2 Micropoint Bio Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.10.3 Micropoint Bio Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Micropoint Bio Main Business Overview
13.10.5 Micropoint Bio Latest Developments
13.11 Xingeyuan Bio
13.11.1 Xingeyuan Bio Company Information
13.11.2 Xingeyuan Bio Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.11.3 Xingeyuan Bio Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Xingeyuan Bio Main Business Overview
13.11.5 Xingeyuan Bio Latest Developments
13.12 Lanyu Bio
13.12.1 Lanyu Bio Company Information
13.12.2 Lanyu Bio Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.12.3 Lanyu Bio Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Lanyu Bio Main Business Overview
13.12.5 Lanyu Bio Latest Developments
13.13 Bohui Innovation
13.13.1 Bohui Innovation Company Information
13.13.2 Bohui Innovation Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.13.3 Bohui Innovation Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Bohui Innovation Main Business Overview
13.13.5 Bohui Innovation Latest Developments
13.14 Rongzhi Bio
13.14.1 Rongzhi Bio Company Information
13.14.2 Rongzhi Bio Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.14.3 Rongzhi Bio Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Rongzhi Bio Main Business Overview
13.14.5 Rongzhi Bio Latest Developments
13.15 Jiangsu Huixian Pharmaceutical
13.15.1 Jiangsu Huixian Pharmaceutical Company Information
13.15.2 Jiangsu Huixian Pharmaceutical Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.15.3 Jiangsu Huixian Pharmaceutical Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Jiangsu Huixian Pharmaceutical Main Business Overview
13.15.5 Jiangsu Huixian Pharmaceutical Latest Developments
13.16 Ruixun Bio
13.16.1 Ruixun Bio Company Information
13.16.2 Ruixun Bio Polymer Microfluidic Chips for in Vitro Diagnostics Product Portfolios and Specifications
13.16.3 Ruixun Bio Polymer Microfluidic Chips for in Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Ruixun Bio Main Business Overview
13.16.5 Ruixun Bio Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
